Transfection of Mammalian Cells with Plasmid DNA by Scrape Loading and Sonication Loading (Gene Expression) MARCUS FECHHEIMER*, JOHN F

Total Page:16

File Type:pdf, Size:1020Kb

Transfection of Mammalian Cells with Plasmid DNA by Scrape Loading and Sonication Loading (Gene Expression) MARCUS FECHHEIMER*, JOHN F Proc. Natl. Acad. Sci. USA Vol. 84, pp. 8463-8467, December 1987 Cell Biology Transfection of mammalian cells with plasmid DNA by scrape loading and sonication loading (gene expression) MARCUS FECHHEIMER*, JOHN F. BOYLANt, SANDRA PARKER*, JESSE E. SISKENt, GORDHAN L. PATEL*, AND STEPHEN G. ZIMMERt *Department of Zoology, University of Georgia, Athens, GA 30602; and tDepartment of Medical Microbiology and Immunology, University of Kentucky Medical Center, Lexington, KY 40536 Communicated by J. Herbert Taylor, August 6, 1987 (receivedfor review March 19, 1987) ABSTRACT Scrape loading and sonication loading are living cells, and we discuss the potential utility of these two recently described methods ofintroducing macromolecules methods as supplements to the existing arsenal of methods into living cells. We have tested the efficacy of these methods for obtaining cellular expression of sequence information for transfection ofmammalian cells with exogenous DNA, using present on molecules of exogenous DNA. selection systems based either on resistance to the drug G418 (Geneticin) or on acquisition of the ability to utilize the salvage pathway of pyrimidine biosynthesis. These loading methods MATERIALS AND METHODS can be employed to generate cell lines that express the gene product of the transfected DNA molecules both transiently and Materials. Dulbecco's modified Eagle's medium, fetal stably. Optimal transfection is observed when the DNA is bovine serum, trypsin, penicillin, streptomycin, Geneticin added to cells in physiological saline lacking divalent cations (G418 sulfate), and Fungizone were supplied by GIBCO. and containing K+ in place of Na'. DNA molecules 7.1 to 30 Hypoxanthine, aminopterin, thymidine, and fluorescein- kilobases long have been introduced by the scrape loading labeled dextran (FD-40) were obtained from Sigma. Murine procedure. In addition, the scrape loading procedure has been fibroblasts deficient in the enzyme thymidine kinase (LTK-) employed for cotransfection and subsequent expression of and the pPVTK4 plasmid, which contains the thymidine nonselectable genes encoded on DNA molecules added in a kinase gene in pBR328, were kindly supplied by Peter mixture with DNA molecules whose expression is selected. Cell Stambrook (University of Cincinnati). Plasmids were grown lines expressing oncogenes or proteins that are important for in Escherichia coli and the DNA was purified by cesium regulation of cell growth and division have been obtained by chloride gradient centrifugation in the presence of ethidium this procedure. The scrape loading procedure is also useful for bromide as described (25). Adenovirus 2 DNA and pSV2neo studies of the cellular changes that occur upon expression of an (26) were purchased from Bethesda Research Laboratories. exogenous gene. As many as 80% ofcells scrape loaded with the HeLa cells, monoclonal antibody (PAB101) reactive with the plasmid pC6, which encodes the simian virus 40 large tumor simian virus 40 (SV40) large tumor (T) antigen (TIB117), and antigen, contained this protein in the nucleus between 1 and 5 c-Ha-ras DNA were purchased from the American Type days after transfection. Thus, scrape loading and sonication Culture Collection. A 6.6-kilobase (kb) BamHI fragment loading are simple, economical, and reproducible methods for containing the ras oncogene was inserted into the BamHI site introduction of DNA molecules into adherent and nonadherent of pBR322. Plasmid pC6, which encodes the SV40 large T cells, and these methods may be useful in the future for antigen, was obtained from Yakov Gluzman (Cold Spring experimentation at both fundamental and applied levels. Harbor Laboratories). The insert was at the EcoRI site of pMKI6 #6. Rat embryo fibroblasts (REF) were produced as Methods for introduction of foreign DNA into living cells in described (27) and WT/O-15.5 D2 (abbreviated D2) cells a form allowing its expression in the recipient cell have been were obtained from Paul Fisher (Columbia University). The widely used in development of human gene therapy technol- murine myeloma cell line P3-X63-Ag8.653 (28) was provided ogies (1), in strategies for plant genetic engineering (2), in by Dan Murfin (University of Georgia). improvement of domestic livestock (3, 4), and in basic Cell Growth. HeLa cells, hepatic tissue culture cells, and research. A number of methods for introduction ofDNA LTK- fibroblasts were grown in Dulbecco's modified eagle's into medium supplemented with 10% fetal bovine serum, penicil- living cells are currently in use (5). These techniques include lin at 50 units/ml, streptomycin at 50 A.g/ml, and Fungizone direct microinjection (6, 7), precipitation with calcium phos- at 2.5 jug/ml (complete medium). The murine myeloma phate (8, 9), membrane breakdown induced by transient P3-X63-Ag8.653 was grown in the same medium containing electric fields (10-12), fusion of erythrocytes or liposomes 50 ,uM 2-mercaptoethanol. REF and D2 cells were grown in (13-16), osmotic lysis of pinosomes (17), centrifugation plastic tissue culture flasks (Corning), using Dulbecco's loading (18), delivery of high-velocity microprojectiles (19), modified Eagle's minimal essential medium supplemented retroviral vectors (20, 21), and the natural plant vector with 10o fetal bovine serum, penicillin at 50 units/ml, Agrobacterium tumefaciens (22). streptomycin at 10 pmg/ml, 0.3% sodium bicarbonate, 1 mM Two additional methods for introduction of macromol- glutamine, and 2.5 mM Hepes. ecules into living cells, scrape loading (23) and sonication Introduction of Thymidine Kinase Gene into LTK- Fibro- loading (24), have recently been described. In this report, we blasts by Scrape Loading and Sonication Loading. In the describe the application of scrape loading and sonication scrape loading procedure, culture medium was removed from loading to the introduction offunctional genetic material into a 10-cm Petri dish with a nearly confluent monolayer of LTK- cells. The cell monolayer was then washed once with The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" Abbreviations: SV4Q, simian virus 40; T antigen, tumor antigen; in accordance with 18 U.S.C. §1734 solely to indicate this fact. REF, rat embryo fibroblasts. 8463 Downloaded by guest on September 24, 2021 8464 Cell Biology: Fechheimer et al. Proc. Natl. Acad. Sci. USA 84 (1987) 5 ml of 10 mM KH2PO4/1.0 mg of glucose per ml/0.1 mM dextran by using either the scraping or the sonication proto- EDTA/140 mM NaCl, pH 7.2 (loading solution). pPVTK4 col. Fluorescein-labeled dextran was added to cells at a final DNA (0-50 Ag/ml) in 1 ml of the loading solution was added concentration of 10 mg/ml, and cells were then treated as to the cells. The cells were then loaded with DNA by scraping described above. Cells exhibiting cytoplasmic fluorescence them from the dish by using a rubber policeman as previously were enumerated by examination of the living cells by described (23). Cells were counted by using a hemocytome- fluorescence microscopy both 6 and 24 hr after loading. ter, and viable cells were identified by exclusion of the dye Control experiments included removal of cells from the trypan blue. In some experiments, variations in the loading substrate by trypsin digestion in the presence of fluorescein- solution were employed in which KCI was used in place of labeled dextran and addition of the fluorescein-labeled dex- NaCl and in which the solutions were supplemented with 2 tran to the cells after scraping or sonication treatments had mM MgC12. been performed. Little or no loading was observed in these In the sonication loading procedure, after removal of control experiments. medium from a nearly confluent monolayer of LTK- fibro- Quantification of Transient Expression by Immunofluores- blasts in a 10-cm dish, the cells were washed with 5 ml of cence Microscopy. REF cells were loaded by scraping with 10 Dulbecco's phosphate-buffered saline without Ca2+ and gg of plasmid pC6 DNA (SV40 large T antigen) in 0.2 ml of Mg2+ (PBS) and removed from the substrate by trypsin PBS. Scraped cells were plated in four-well chamber slides, digestion. The cells were diluted into 2 ml of complete fixed 0, 1, 2, 3, 4, or 5 days later, and stained with antibody medium, sedimented, resuspended in 10 ml of loading solu- reactive with the SV40 large T antigen to detect expression tion, and resedimented. The cells were then suspended in 1 of the transformed gene product as described (30), except ml of loading solution containing pPVTK4 DNA (0-50 methanol was used as the fixative agent. Positive cells gg/ml) in a sterile 12 x 75 mm plastic round-bottom tube and exhibited bright nuclear fluorescence characteristic of the sonicated with three bursts of 0.5-sec duration at power large T antigen in SV40-infected cells. setting 1 of a Branson model 200 sonicator equipped with a two-step tapered microtip fitted with a plastic sleeve. This sonication loading method is an adaptation of a technique RESULTS developed for use with Dictyostelium discoideum (24, 29). Trial experiments indicated that the viability of LTK- fibro- Use of Scrape Loading and Sonication Loading for Trans- blasts under these conditions is approximately 70%. The fection of Mammalian Cells. Scrape loading (23) and sonica- number of viable cells was determined by counting in the tion loading (24) have both been employed previously for presence of trypan blue. introduction of macromolecules such as fluorescently-la- One million viable cells loaded with pPVTK4 DNA either beled dextran and protein molecules into the cytoplasm of by scraping or by sonication were diluted into 10 ml of living eukaryotic cells. Previous use of the sonication loading complete culture medium supplemented with 100 ,M hypo- method has, however, been restricted to experiments with xanthine and 16 ,M thymidine (HT medium) in a 10-cm amoebae of the cellular slime mold D.
Recommended publications
  • Rnai in Primary Cells and Difficult-To-Transfect Cell Lines
    Automated High Throughput Nucleofection® RNAi in Primary Cells and Difficult-to-Transfect Cell Lines Claudia Merz, Bayer Schering Pharma AG, Berlin, Germany; Andreas Schroers, amaxa AG, Cologne, Germany; Eric Willimann, Tecan AG, Männedorf, Switzerland. Introduction Materials & Methods - Workflow Using primary cells for RNAi based applications such as target identification or – validation, requires a highly efficient transfection displaying the essential steps of the automated Nucleofector® Process: technology in combination with a reliable and robust automation system. To accomplish these requirements we integrated the amaxa 1. Transfer of the cells to the Nucleocuvette™ plate, 96-well Shuttle® in a Tecan Freedom EVO® cell transfection workstation which is based on Tecan’s Freedom EVO® liquid handling 2. Addition of the siRNA, (Steps 1 and 2 could be exchanged), platform and include all the necessary components and features for unattended cell transfection. 3. Nucleofection® process, 4. Addition of medium, Count Cells 5. Transfer of transfected cells to cell culture plate for incubation ® Nucleofector Technology prior to analysis. Remove Medium The 96-well Shuttle® combines high-throughput compatibility with the Nucleofector® Technology, which is a non-viral transfection method ideally suited for primary cells and hard-to-transfect cell lines based on a combination of buffers and electrical parameters. Nucleocuvette Plate Add Nucleofector +– The basic principle and benefits of the (empty) Solution Cell of interest Gene of interest Nucleofector®
    [Show full text]
  • Plant Molecular Farming: a Viable Platform for Recombinant Biopharmaceutical Production
    plants Review Plant Molecular Farming: A Viable Platform for Recombinant Biopharmaceutical Production Balamurugan Shanmugaraj 1,2, Christine Joy I. Bulaon 2 and Waranyoo Phoolcharoen 1,2,* 1 Research Unit for Plant-Produced Pharmaceuticals, Chulalongkorn University, Bangkok 10330, Thailand; [email protected] 2 Department of Pharmacognosy and Pharmaceutical Botany, Faculty of Pharmaceutical Sciences Chulalongkorn University, Bangkok 10330, Thailand; [email protected] * Correspondence: [email protected]; Tel.: +66-2-218-8359; Fax: +66-2-218-8357 Received: 1 May 2020; Accepted: 30 June 2020; Published: 4 July 2020 Abstract: The demand for recombinant proteins in terms of quality, quantity, and diversity is increasing steadily, which is attracting global attention for the development of new recombinant protein production technologies and the engineering of conventional established expression systems based on bacteria or mammalian cell cultures. Since the advancements of plant genetic engineering in the 1980s, plants have been used for the production of economically valuable, biologically active non-native proteins or biopharmaceuticals, the concept termed as plant molecular farming (PMF). PMF is considered as a cost-effective technology that has grown and advanced tremendously over the past two decades. The development and improvement of the transient expression system has significantly reduced the protein production timeline and greatly improved the protein yield in plants. The major factors that drive the plant-based platform towards potential competitors for the conventional expression system are cost-effectiveness, scalability, flexibility, versatility, and robustness of the system. Many biopharmaceuticals including recombinant vaccine antigens, monoclonal antibodies, and other commercially viable proteins are produced in plants, some of which are in the pre-clinical and clinical pipeline.
    [Show full text]
  • Widespread Gene Transfection Into the Central Nervous System of Primates
    Gene Therapy (2000) 7, 759–763 2000 Macmillan Publishers Ltd All rights reserved 0969-7128/00 $15.00 www.nature.com/gt NONVIRAL TRANSFER TECHNOLOGY RESEARCH ARTICLE Widespread gene transfection into the central nervous system of primates Y Hagihara1, Y Saitoh1, Y Kaneda2, E Kohmura1 and T Yoshimine1 1Department of Neurosurgery and 2Division of Gene Therapy Science, Department of Molecular Therapeutics, Osaka University Graduate School of Medicine, 2-2 Yamadaoka, Suita, Osaka 565-0871, Japan We attempted in vivo gene transfection into the central ner- The lacZ gene was highly expressed in the medial temporal vous system (CNS) of non-human primates using the hem- lobe, brainstem, Purkinje cells of cerebellar vermis and agglutinating virus of Japan (HVJ)-AVE liposome, a newly upper cervical cord (29.0 to 59.4% of neurons). Intrastriatal constructed anionic type liposome with a lipid composition injection of an HVJ-AVE liposome–lacZ complex made a similar to that of HIV envelopes and coated by the fusogenic focal transfection around the injection sites up to 15 mm. We envelope proteins of inactivated HVJ. HVJ-AVE liposomes conclude that the infusion of HVJ-AVE liposomes into the containing the lacZ gene were applied intrathecally through cerebrospinal fluid (CSF) space is applicable for widespread the cisterna magna of Japanese macaques. Widespread gene delivery into the CNS of large animals. Gene Therapy transgene expression was observed mainly in the neurons. (2000) 7, 759–763. Keywords: central nervous system; primates; gene therapy; HVJ liposome Introduction ever, its efficiency has not been satisfactory in vivo. Recently HVJ-AVE liposome, a new anionic-type lipo- Despite the promising results in experimental animals, some with the envelope that mimics the human immuno- gene therapy has, so far, not been successful in clinical deficiency virus (HIV), has been developed.13 Based upon 1 situations.
    [Show full text]
  • Therapeutic Recombinant Protein Production in Plants: Challenges and Opportunities
    Received: 25 April 2019 | Revised: 23 July 2019 | Accepted: 20 August 2019 DOI: 10.1002/ppp3.10073 REVIEW Therapeutic recombinant protein production in plants: Challenges and opportunities Matthew J. B. Burnett1 | Angela C. Burnett2 1Yale Jackson Institute for Global Affairs, New Haven, CT, USA Societal Impact Statement 2Brookhaven National Laboratory, Upton, Therapeutic protein production in plants is an area of great potential for increasing NY, USA and improving the production of proteins for the treatment or prevention of disease Correspondence in humans and other animals. There are a number of key benefits of this technique Angela C. Burnett, Brookhaven National for scientists and society, as well as regulatory challenges that need to be overcome Laboratory, Upton, NY, USA. Email: [email protected] by policymakers. Increased public understanding of the costs and benefits of thera‐ peutic protein production in plants will be instrumental in increasing the acceptance, Funding information Biotechnology and Biological Sciences and thus the medical and veterinary impact, of this approach. Research Council; Margaret Claire Ryan Summary Fellowship Fund at the Yale Jackson Institute for Global Affairs; U.S. Department Therapeutic recombinant proteins are a powerful tool for combating many diseases of Energy, Grant/Award Number: DE‐ which have previously been hard to treat. The most utilized expression systems are SC0012704 Chinese Hamster Ovary cells and Escherichia coli, but all available expression sys‐ tems have strengths and weaknesses regarding development time, cost, protein size, yield, growth conditions, posttranslational modifications and regulatory approval. The plant industry is well established and growing and harvesting crops is easy and affordable using current infrastructure.
    [Show full text]
  • Eukaryotic Expression
    Molecular Biology Problem Solver: A Laboratory Guide. Edited by Alan S. Gerstein Copyright © 2001 by Wiley-Liss, Inc. ISBNs: 0-471-37972-7 (Paper); 0-471-22390-5 (Electronic) 16 Eukaryotic Expression John J. Trill, Robert Kirkpatrick, Allan R. Shatzman, and Alice Marcy Section A: A Practical Guide to Eukaryotic Expression . 492 Planning the Eukaryotic Expression Project . 493 What Is the Intended Use of the Protein and What Quantity Is Required? . 493 What Do You Know about the Gene and the Gene Product? . 496 Can You Obtain the cDNA? . 497 Expression Vector Design and Subcloning . 498 Selecting an Appropriate Expression Host . 501 Selecting an Appropriate Expression Vector . 506 Implementing the Eukaryotic Expression Experiment . 511 Media Requirements, Gene Transfer, and Selection . 511 Scale-up and Harvest . 514 Gene Expression Analysis . 515 Troubleshooting . 517 Confirm Sequence and Vector Design . 517 Investigate Alternate Hosts . 519 A Case Study of an Expressed Protein from cDNA to Harvest.......................................... 519 Summary . 521 Section B: Working with Baculovirus . 521 Planning the Baculovirus Experiment . 521 491 Is an Insect Cell System Suitable for the Expression of Your Protein? . 521 Should You Express Your Protein in an Insect Cell Line or Recombinant Baculovirus? . 522 Procedures for Preparing Recombinant Baculovirus . 524 Criteria for Selecting a Transfer Vector . 524 Which Insect Cell Host Is Most Appropriate for Your Situation? . 525 Implementing the Baculovirus Experiment . 527 What’s the Best Approach to Scale-Up? . 527 What Special Considerations Are There for Expressing Secreted Proteins? . 527 What Special Considerations Are There for Expressing Glycosylated Proteins? . 528 What Are the Options for Expressing More Than One Protein?....................................
    [Show full text]
  • Food and Drug Law Journal
    FOOD AND DRUG LAW JOURNAL EDITOR IN CHIEF Judy Rein EDITORIAL ADVISORY BOARD CHAIR VICE CHAIR FACULTY ADVISOR Laurie Lenkel Robert Giddings Joseph A. Page FDA – OC Hutchison PLLC Georgetown University Law Center ________________________________ Anthony Anscombe James Flaherty Francis Palumbo Sedgwick LLP Fresenius Medical University of Maryland School of Pharmacy Peter Barton Hutt Abraham Gitterman Covington & Burling Arnold & Porter LLP Sandra Retzky FDA – CTP Barbara Binzak Kimberly Gold Blumenfeld Norton Rose Fulbright Joan Rothenberg Buchanan Ingersoll & LLP FDA - CFSAN Rooney PC John Johnson Jodi Schipper Catherine Clements FDA Imports FDA – CDER Express Scripts Alan Katz Christopher van Gundy Kellie Combs toXcel, LLC Keller and Heckman Ropes & Gray LLP Sara Koblitz James Woodlee Nathan Cortez Fish & Richardson Kleinfeld Kaplan & Becker LLP Southern Methodist University Valerie Madamba Emily Wright Blue Apron Pfizer Brian Dahl Dahl Compliance Alan Minsk Kimberly Yocum Consulting LLC Arnall Golden Gregory TC Heartland LLC LLP Sandra dePaulis Lowell Zeta FDA – CVM Nicole Negowetti Hogan Lovells The Good Food Ian Fearon Institute Patricia Zettler British American Tobacco Georgia State James O’Reilly University Law School University of Cincinnati OFFICERS OF THE FOOD AND DRUG LAW INSTITUTE CHAIR: Allison M. Zieve, Public Citizen Litigation Group VICE CHAIR: Jeffrey N. Gibbs, Hyman, Phelps & McNamara, P.C. TREASURER: Frederick R. Ball, Duane Morris LLP GENERAL COUNSEL/SECRETARY: Joy J. Liu, Vertex Pharmaceuticals IMMEDIATE PAST CHAIR: Sheila Hemeon-Heyer, Heyer Regulatory Solutions LLC PRESIDENT & CEO: Amy Comstock Rick GEORGETOWN UNIVERSITY LAW CENTER STUDENT EDITOR IN CHIEF Dana Shaker STUDENT MANAGING EDITORS Jacob Klapholz Christine Rea STUDENT NOTES EDITOR SYMPOSIUM EDITOR Lauren Beegle Alexander P.
    [Show full text]
  • The Art of Transfection (Poster / Pdf)
    TRANSDUCTION NON-VIRAL TRANSFECTION Transduction is the process of using vectors including retroviruses, lentiviruses, adenoviruses, PACKAGE DELIVERY: Chemical Chemical transfection adeno-associated viruses, or hybrids to deliver genetic payloads into cells. Generally, a plasmid transfection reagent containing mRNA carrying genes flanked by viral sequences is first transfected into a producer cell with other reagent virus-associated (packaging) plasmids. In the producer cells, virions form that contain the gene The Art of Transfection of interest. For safety, no plasmid used in the process contains all of the necessary sequences Inserting genetic material into mammalian and insect cells without killing them can be a challenge, CHEMICAL TRANSFECTION for virion formation, and only the plasmid carrying the gene of interest contains signals that but scientists have developed several ways to perform this intricate task. Transfection is the process of Functional proteins or allow it to be packaged into virions. Researchers then extract, purify, and use the virions from Complexation structural components released Chemical carriers represent the most straightforward and widespread tools for gene delivery the producer cells to insert DNA into other cells to stably or transiently express the DNA of introducing nucleic acids (plasmid DNA or messenger, short interfering, or micro RNA) into a cell. from cell or into cytoplasm experiments in mammalian cells. Chemical transfection experiments follow a simple workflow and interest. The transferred genetic material, which lacks viral genes, cannot generate new viruses. Researchers accomplish this with nonviral methods (chemical or physical transfection), or with viral provide high efficiency nucleic acid delivery for the most commonly used cells as well as many methods, commonly referred to as transduction.
    [Show full text]
  • Recent Advances in Genome Editing Tools in Medical Mycology Research
    Journal of Fungi Review Recent Advances in Genome Editing Tools in Medical Mycology Research Sanaz Nargesi 1 , Saeed Kaboli 2,3,* , Jose Thekkiniath 4,*, Somayeh Heidari 5 , Fatemeh Keramati 6, Seyedmojtaba Seyedmousavi 5,7 and Mohammad Taghi Hedayati 1,5,* 1 Department of Medical Mycology, School of Medicine, Mazandaran University of Medical Sciences, Sari 481751665, Iran; [email protected] 2 Department of Medical Biotechnology, School of Medicine, Zanjan University of Medical Sciences, Zanjan 4513956111, Iran 3 Cancer Gene Therapy Research Center, Zanjan University of Medical Sciences, Zanjan 4513956111, Iran 4 Fuller Laboratories, 1312 East Valencia Drive, Fullerton, CA 92831, USA 5 Invasive Fungi Research Center, Communicable Diseases Institute, Mazandaran University of Medical Sciences, Sari 481751665, Iran; [email protected] (S.H.); [email protected] (S.S.) 6 Department of Pathobiology, Faculty of Veterinary Medicine, Urmia University, Urmia 5756151818, Iran; [email protected] 7 Clinical Center, Microbiology Service, Department of Laboratory Medicine, National Institutes of Health, Bethesda, MD 20892, USA * Correspondence: [email protected] (S.K.); [email protected] (J.T.); [email protected] (M.T.H.) Abstract: Manipulating fungal genomes is an important tool to understand the function of tar- get genes, pathobiology of fungal infections, virulence potential, and pathogenicity of medically important fungi, and to develop novel diagnostics and therapeutic targets. Here, we provide an overview of recent advances in genetic manipulation techniques used in the field of medical mycol- Citation: Nargesi, S.; Kaboli, S.; ogy. Fungi use several strategies to cope with stress and adapt themselves against environmental Thekkiniath, J.; Heidari, S.; Keramati, effectors. For instance, mutations in the 14 alpha-demethylase gene may result in azole resistance in F.; Seyedmousavi, S.; Hedayati, M.T.
    [Show full text]
  • An Improved Syringe Agroinfiltration Protocol to Enhance Transformation Efficiency by Combinative Use of 5-Azacytidine, Ascorbat
    plants Article An Improved Syringe Agroinfiltration Protocol to Enhance Transformation Efficiency by Combinative Use of 5-Azacytidine, Ascorbate Acid and Tween-20 Huimin Zhao 1, Zilong Tan 2, Xuejing Wen 2 and Yucheng Wang 1,2,* 1 State Key Laboratory of Tree Genetics and Breeding, Northeast Forestry University, Harbin 150040, China; [email protected] 2 Key Laboratory of Biogeography and Bioresource in Arid Land, Xinjiang Institute of Ecology and Geography, Chinese Academy of Sciences, Urumqi 830011, China; [email protected] (Z.T.); [email protected] (X.W.) * Correspondence: [email protected]; Tel.: +86-451-82190607 Academic Editor: Milan S. Stankovic Received: 1 January 2017; Accepted: 9 February 2017; Published: 14 February 2017 Abstract: Syringe infiltration is an important transient transformation method that is widely used in many molecular studies. Owing to the wide use of syringe agroinfiltration, it is important and necessary to improve its transformation efficiency. Here, we studied the factors influencing the transformation efficiency of syringe agroinfiltration. The pCAMBIA1301 was transformed into Nicotiana benthamiana leaves for investigation. The effects of 5-azacytidine (AzaC), Ascorbate acid (ASC) and Tween-20 on transformation were studied. The β-glucuronidase (GUS) expression and GUS activity were respectively measured to determine the transformation efficiency. AzaC, ASC and Tween-20 all significantly affected the transformation efficiency of agroinfiltration, and the optimal concentrations of AzaC, ASC and Tween-20 for the transgene expression were identified. Our results showed that 20 µM AzaC, 0.56 mM ASC and 0.03% (v/v) Tween-20 is the optimal concentration that could significantly improve the transformation efficiency of agroinfiltration.
    [Show full text]
  • Micro-RNA Modulation of Insect Virus Replication Verna Monsanto-Hearne and Karyn N
    Micro-RNA Modulation of Insect Virus Replication Verna Monsanto-Hearne and Karyn N. Johnson* School of Biological Sciences, University of Queensland, Brisbane, Australia. *Correspondence: [email protected] htps://doi.org/10.21775/cimb.034.061 Abstract Saleh, 2012; Xu and Cherry, 2014; Mussabekova Te outcome of virus infection in insects is impacted et al., 2017). Many molecular components medi- by regulation of both host and virus gene expres- ate and are mediated by this host–virus cross-talk, sion. A class of small RNAs called micro-RNAs including microRNAs. (miRNA) have emerged as important regulators of microRNAs (miRNAs) are a large class of highly gene expression that can infuence the outcome of conserved, ≈ 22 nt non-coding RNAs that regulate virus infection. miRNA regulation occurs at a com- gene expression. Compared to the more upstream paratively late stage of gene expression, allowing for regulatory mechanisms such as transcriptional rapid control and fne-tuning of gene expression regulation and chromatin remodelling, regulation levels. Here we discuss the biogenesis of miRNAs by miRNA occurs at a later stage of gene expres- from both host and virus genomes, the interactions sion, allowing for rapid control and fne-tuning of that lead to regulation of gene expression, and the gene expression levels (Chen et al., 2013). Comple- miRNA–mRNA interactions that lead to either mentary binding of at least the seed region (second antivirus or provirus consequences in the course of to eighth nucleotide from the 5′-end) of the ≈ 22 nt virus
    [Show full text]
  • Highly Efficient Protoplast Isolation and Transient Expression System
    International Journal of Molecular Sciences Article Highly Efficient Protoplast Isolation and Transient Expression System for Functional Characterization of Flowering Related Genes in Cymbidium Orchids Rui Ren 1 , Jie Gao 1, Chuqiao Lu 1, Yonglu Wei 1, Jianpeng Jin 1, Sek-Man Wong 2,3,4, Genfa Zhu 1,* and Fengxi Yang 1,* 1 Guangdong Key Laboratory of Ornamental Plant Germplasm Innovation and Utilization, Environmental Horticulture Research Institute, Guangdong Academy of Agricultural Sciences, Guangzhou 510640, China; [email protected] (R.R.); [email protected] (J.G.); [email protected] (C.L.); [email protected] (Y.W.); [email protected] (J.J.) 2 Department of Biological Sciences, National University of Singapore (NUS), 14 Science Drive 4, Singapore 117543, Singapore; [email protected] 3 National University of Singapore Suzhou Research Institute (NUSRI), Suzhou Industrial Park, Suzhou 215000, China 4 Temasek Life Sciences Laboratory, National University of Singapore, 1 Research Link, Singapore 117604, Singapore * Correspondence: [email protected] (G.Z.); [email protected] (F.Y.) Received: 28 February 2020; Accepted: 24 March 2020; Published: 25 March 2020 Abstract: Protoplast systems have been proven powerful tools in modern plant biology. However, successful preparation of abundant viable protoplasts remains a challenge for Cymbidium orchids. Herein, we established an efficient protoplast isolation protocol from orchid petals through optimization of enzymatic conditions. It requires optimal D-mannitol concentration (0.5 M), enzyme concentration (1.2 % (w/v) cellulose and 0.6 % (w/v) macerozyme) and digestion time (6 h). With this protocol, the highest yield (3.50 107/g fresh weight of orchid tissue) and viability (94.21%) of × protoplasts were obtained from flower petals of Cymbidium.
    [Show full text]
  • Grapevine Protoplasts As a Transient Expression System for Comparison
    Grapevine Protoplasts as a Transient Expression System for Comparison of Stilbene Synthase Genes Containing cGMP-Responsive Promoter Elements Ilka Brehm, Regina Preisig-Müller and Helmut Kindi Fachbereich Chemie der Philipps-Universität, D-35032 Marburg, Germany Z. Naturforsch. 54c, 220-229 (1999) received December 15, 1998/January 7, 1999 cGMP, Grapevine Protoplasts, Pine, Promoter, Elicitor-Responsive, Stilbene Synthase Gene, Vitis A method for preparing elicitor-responsive protoplasts from grapevine cells kept in suspen­ sion culture was established. The protoplasts were employed in order to perform transient gene expression experiments produced by externally added plasmids. Using the gene coding for bacterial ß-glucuronidase as the reporter gene, the transient expression under the control of various promoters of stilbene synthase genes were analyzed. The elicitor-responsiveness of promoters from grapevine genes and heterologous promoters were assayed: the grapevine stilbene synthase gene VST-1 and pine stilbene synthase genes PST-1, PST-2 and PST-3. Compared to the expression effected by the cauliflower mosaic virus 35S RNA-promoter, the stilbene synthase promoters caused a 2-5-fold increase in GUS-activity. Incubation of transformed protoplasts with fungal cell wall further stimulated the stilbene synthase promot­ ers but not the 35S RNA-promoter. An even more pronounced differentiation between the promoters was observed when cGMP was included in the transient expression assays. Instead of treating transformed protoplasts with fungal cell wall we administered simultaneously cGMP and the plasmid to be tested. The cGMP-responsive increase was (a) specific concern­ ing the nucleotide applied, (b) characteristic of grapevine protoplasts, and (c) not seen with shortened promoter-GUS constructs or GUS under the control of the 35S RNA-promoter.
    [Show full text]